Conference
P2-15-05: Excision of the Primary Tumour in Patients with Metastatic Breast Cancer – Will E2108 Provide the Definitive Answer?
Abstract
Abstract
Background: Approximately 10% of new breast cancer patients will present with overt synchronous metastatic disease. Controversy exists about the optimal local management of these patients. While several series suggest that removal of primary tumour is associated with a survival benefit, the retrospective nature of these studies raises considerable methodological challenges. We decided to evaluate the experience at our …
Authors
Samiee S; Berardi P; Bouganim N; Vandermeer L; Arnaout A; Mirsky D; Dent S; Caudrelier J-M; Chasen M; Clemons M
Volume
71
Publisher
American Association for Cancer Research (AACR)
Publication Date
December 15, 2011
DOI
10.1158/0008-5472.sabcs11-p2-15-05
Conference proceedings
Cancer Research
Issue
24_Supplement
ISSN
0008-5472